Q16288 (NTRK3_HUMAN) Homo sapiens (Human)

NT-3 growth factor receptor UniProtKBInterProSTRINGInteractive Modelling

839 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5); 1 identical sequence: Homo sapiens: X5D2R1

Available Structures

5 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of TRKc in complex with 3-((6-(4-aminophenyl)imidazo[1,2-a]pyrazin-3-yl)ethynyl)-…monomer528-837
DZ6;PO4;
Assess
crystal structure of TRKc in complex with 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methyl-N-(3-((4- …monomer528-837
DZC;
Assess
Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor modelsmonomer530-832
CL;0F4;
Assess
(R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK …monomer530-831
4EJ;GOL;CL;
Assess
NT3 BINDING DOMAIN OF HUMAN TRKC RECEPTORmonomer300-412
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5kmj.1.Amonomer0.73510-838
76.22
Assess
7n3t.1.Amonomer0.6232-398
38.24
Assess

12 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27n3t.1.Amonomer0.6232-399
38.42
Assess
Isoform 23zyo.1.Amonomer0.57103-300
27.41
Assess
Isoform 23dmk.1.Bmonomer0.56209-426
22.33
Assess
Isoform 23b43.1.Amonomer0.54210-427
22.64
Assess
Isoform 25xwt.1.Amonomer0.52208-396
22.34
Assess
Isoform 22e9w.1.Amonomer0.51210-426
17.13
Assess
Isoform 35kmj.1.Amonomer0.77510-824
76.22
Assess
Isoform 37n3t.1.Amonomer0.6032-398
38.24
Assess
Isoform 45kmj.1.Amonomer0.73502-830
76.22
Assess
Isoform 47n3t.1.Amonomer0.6132-399
38.42
Assess
Isoform 55kmj.1.Amonomer0.77502-816
76.22
Assess
Isoform 57n3t.1.Amonomer0.6132-399
38.42
Assess